Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpesvirus 2, Human”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Early research (Phase 1)Ended earlyNCT03103971
What this trial is testing

HuJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma+14 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Ended earlyNCT03146403
What this trial is testing

Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection

Who this might be right for
Genital HerpesHSV-2 Infection
Genocea Biosciences, Inc. 33
Testing effectiveness (Phase 2)Study completedNCT00530777
What this trial is testing

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding

Who this might be right for
HIV InfectionsHerpes Simplex
University of Washington 148
Large-scale testing (Phase 3)Study completedNCT04693637
What this trial is testing

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Adenovirus InfectionBK Virus InfectionCytomegalovirus Infections+3 more
AlloVir 26
Testing effectiveness (Phase 2)Study completedNCT00158483
What this trial is testing

Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)

Who this might be right for
UlcerHerpes Genitalis
French National Agency for Research on AIDS and Viral Hepatitis 449
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04979975
What this trial is testing

Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes
UBP Greater China (Shanghai) Co., Ltd 200
Not applicableStudy completedNCT03080961
What this trial is testing

The VIBLOK SAfety and perFormancE Trial

Who this might be right for
HSV-2 InfectionGenital Herpes
CLJI Worldwide 82
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Large-scale testing (Phase 3)Study completedNCT00432523
What this trial is testing

Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)

Who this might be right for
MeaslesMumpsVaricella
Merck Sharp & Dohme LLC 752
Post-approval studies (Phase 4)Study completedNCT00464542
What this trial is testing

Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study

Who this might be right for
Bacterial Vaginosis
University of Pittsburgh 12
Testing effectiveness (Phase 2)Study completedNCT02837575
What this trial is testing

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

Who this might be right for
Herpes Genitalis
Vical 261
Post-approval studies (Phase 4)Ended earlyNCT00495716
What this trial is testing

Effect of HSV-2 Suppressive Therapy on Sexual Behavior

Who this might be right for
Genital Herpes
University of Washington 72
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Testing effectiveness (Phase 2)Study completedNCT00371592
What this trial is testing

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Who this might be right for
HIV InfectionsHerpesvirus 2, Human
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT01043081
What this trial is testing

Sexually Transmitted Infections Among African American Women Who Have Sex With Women

Who this might be right for
Sexually Transmitted InfectionsHIV Infections
University of Mississippi Medical Center 300
Testing effectiveness (Phase 2)Study completedNCT02515175
What this trial is testing

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 131
Large-scale testing (Phase 3)Study completedNCT00194519
What this trial is testing

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Who this might be right for
HIV InfectionHerpes Simplex, GenitalSexually Transmitted Diseases
University of Washington 3,408
Testing effectiveness (Phase 2)UnknownNCT03595995
What this trial is testing

Trial to Evaluate the Safety and Efficacy of UB-621

Who this might be right for
Genital Herpes
United BioPharma 80
Early research (Phase 1)Ended earlyNCT00003567
What this trial is testing

Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 8
Next Page